Clinical Trial Update: Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 single-blind, controlled study evaluating the safety and immunogenicity of a recombinant MVA-based HIV vaccine in individuals with HIV infection; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Recombinant MVA HIV vaccine (Modified Vaccinia Ankara-based HIV vaccine)

Snippet

Sponsor: Bavarian Nordic | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED